Ulrich‐Peter Rohr - Concepedia

Author

Ulrich‐Peter Rohr

Heinrich Heine University Düsseldorf ORCID

Also Known As

U P Rohr, U Rohr, U. P. Rohr, U. Rohr, U.-P. Rohr, U.P Rohr, Ulrich-Peter Rohr, Ulrich‐Peter Rohr

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Heinrich Heine University Düsseldorf Roche (Switzerland)German Cancer Research Center Heidelberg University Memorial Sloan Kettering Cancer Center

About

Ulrich‐Peter Rohr is an author at Heinrich Heine University Düsseldorf specializing in medicine, immunology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	195
2	Immunology	2	2	159
3	Health Sciences	1	1	10
4	Biostatistics	1	1	26
5	Cell Biology	1	1	22

Ulrich‐Peter Rohr

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Bevacizumab Safety in Patients with Central Nervous System Metastases Benjamin Besse, Susan Frances Lasserre, Peter G. Compton, Clinical Cancer Research	2009	239
The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report Ulrich‐Peter Rohr, Carmen Binder, Thomas Dieterle, PLoS ONE	2016	226
Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies Herbert I. Hurwitz, Leonard B. Saltz, Eric Van Cutsem, Journal of Clinical Oncology	2011	218
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies James T. Cassidy, Leonard B. Saltz, Bruce J. Giantonio, Journal of Cancer Research and Clinical Oncology	2009	159
Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells Ulrich Steidl, Ralf Kronenwett, Ulrich‐Peter Rohr, Blood	2002	148
Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody Guido Kobbe, Philipp Schneider, Ulrich‐Peter Rohr, Bone Marrow Transplantation InflammationTransplantationAutoimmune DiseaseImmunosuppressive TherapyImmunology	2001	137
Tumor immune escape by the loss of homeostatic chemokine expression Andor Pivarcsi, Anja Müller, Andreas Hippe, Proceedings of the National Academy of Sciences	2007	132
Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers Astrid Rohrbeck, Judith Neukirchen, Michael Rosskopf, Journal of Translational Medicine	2008	68
A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma Ingmar Bruns, Ulrich Steidl, Ralf Kronenwett, Transfusion	2005	67
FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non–Small Cell Lung Cancer, a Collaborative Project Orbis Review Abigail L. Koch, Paz J. Vellanki, Nicole Drezner, Clinical Cancer Research	2021	58

Page 1